Catalyst Wire Dossier Catalyst Wire Dossier

Virosomal influenza vaccine (formulated with WHO-recommended strains)

· Crucell Holland BV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Virosomal influenza vaccine (formulated with WHO-recommended strains), covering 2013-12-20 to 2013-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains [NA]

See pricing